Eczema vaccinatum as an adverse event following exposure to vaccinia virus: Case definition & guidelines of data collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5725-5734

  Nell, Patricia ^a   Kohl, Katrin S ^b   Graham, Philip L ^c   LaRussa, Philip S ^c   Marcy, S Michael ^d   Fulginiti, Vincent A ^e   Martin, Bryan ^f   Trolin, Ingrid ^g   Norton, Scott A ^f   Neff, John M ^h  

^a San Antonio River Authority   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Columbia University ^*  (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g Medical Product Agency   (Sweden)

^h SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Adverse event; Case definition; Eczema vaccinatum; Guidelines; Immunization; Smallpox vaccine; Vaccinia virus

Indexed keywords

VACCINIA VACCINE;

ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; DECISION MAKING; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EXPOSURE; DRUG SAFETY; ECZEMA; ECZEMA VACCINATUM; GENERALIZED VACCINIA; HISTIOCYTOMA; HUMAN; IMMUNIZATION; INOCULATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE VACCINIA; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VACCINIA VIRUS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNIZATION; KAPOSI VARICELLIFORM ERUPTION; SAFETY; SMALLPOX VACCINE; TERMINOLOGY; VACCINIA VIRUS;

EID: 34447294557     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.085     Document Type: Article

References (36)

1. World Health Organization. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980;55:148.
2. Henderson D.A. About the first National Symposium on Medical and Public Health Response to Bioterrorism. Emerg Infect Dis 5 (1999) 492-493
3. Shalala D. Bioterrorism; how prepared are we?. Emerg Infect Dis 5 (1999) 492-493
4. Russel P.K. Vaccines in civilian defense against bioterrorism. Emerg Infect Dis 5 (1999) 531-533
5. Frey S.E., Newman F.K., Cruz J., Shelton W.B., Tennant J.M., Polach T., et al. Dose-related Effects of smallpox vaccine. N Engl J Med 346 (2002) 1275-1280
6. Frey S.E., Couch R.B., Tacket C.O., Treanor J.J., Wolff M., Newman F.K., et al. Clinical responses to undiluted and diluted smallpox vaccine. N Eng J Med 346 (2002) 1265-1274
7. Frey S.E., Newman F.K., Yan L., and Belshe R.B. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289 (2003) 3295-3299
8. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Michael Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine (2007)
9. Centers for Disease Control and Prevention. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR 2006;55(RR-1):1-16.
10. CDC. Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR 2001; 50(RR10);1-25. Report available on the world wide web: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5010a1.htm (last accessed February 9, 2006).
11. CDC. Smallpox Vaccination and adverse reactions. Guidance for Clinicians. MMWR 2003;52(RR-4):1-28. Available on the world wide web: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5204a1.htm (last accessed February 9, 2006).
12. Fulginity V.A., Papier A., Lane M., Neff J.M., and Henderson D.A. Smallpox vaccination: A review. Part II. Adverse events. CID 37 (2003) 251-271
13. Plaut M., and Tinkle S.S. Editorial: risks of smallpox vaccination: 200 years after Jenner. J Allergy Clin Immunol 112 (2003) 683-685
14. Aragon T.J., Ulrich S., Fernyak S., and Rutherford G.W. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968. BMC Public Health 3 (2003) 26-38
15. Copeman P.W.M., and Wallace H.J. Eczema vaccinatum. Br Med J 2 (1964) 906-908
16. Williams H.C., Jburney P.G., Hay R.J., Archer C.B., Shipley M.J., Ahunter J.J., et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131 (1994) 383-396 397-405, 406-416
17. Williams H.C., Burney P.G., Pembroke A.C., and Hay R.J. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 131 (1994) 406-416
18. Boguniewicz M., and Leung D.Y.M. Atopic dermatitis. Middleton's allergy principles and practice, ED 6 (2003), Mosby p. 1559-61
19. Salo O.P., and Valle M.J. Eczema vaccinatum in a family with Darier's disease. Br J Dermatol 89 (1973) 417-422
20. Cooper S.M., and Burge S.M. Darier's disease: epidemiology, pathophysiology, and management. Am J Clin Dermatology 4 (2003) 97-105
21. Burge S. Darier's disease-the clinical features and pathogenesis. Clin Exp Dermatol 19 (1994) 193-205
22. Wollenberg A., Wetzel S., Burgdorf W.H.C., and Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 112 (2003) 667-674
23. Engler R.F.M., Kenner J., and Leung D.Y.M. J Allergy Clin Immun 110 (2002) 1-9
24. Naleway A.L., Belongia E.A., Greenlee R.T., Kieke B.A., Chen R.T., and Shay D.K. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med 139 (2003) 1-7
25. Williams H.C., Burney P.G., Strachan D., and Hay R.J. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer vaccination of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 131 (1994) 397-405
26. Larsen F.S., and Hanifin J.M. Epidemiolgy of atopic dermatitis. Immunol Allerg Clin N Am 22 (2002) 1-23
27. Neff J.M., Lane J.M., Fulginiti V.A., and Henderson D.A. Contact vaccinia-transmission of vaccinia from smallpox vaccination. JAMA 288 (2002) 1901-1905
28. Kempe C.H. Studies on smallpox and complications of smallpox vaccination. Pediatrics 26 (1960) 177-189
29. Feery B.J. Adverse reactions after smallpox vaccination. Med J Aust 2 (1977) 180-183
30. Haim M., Gdalevich M., Mimouni D., Ashkenazi I., and Shemer J. Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys. Mil Med 165 (2000) 287-289
31. Adels B.R., and Oppe T.E. Treatment of eczema vaccinatum with N-methylisatin beta-thiosemicarbazone. Lancet 1 (1966) 18-20
32. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ (last accessed February 9, 2006).
33. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm (last accessed February 9, 2006).
34. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm (last accessed February 9, 2006).
35. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896-900. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006).
36. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006).